Glaxo drug shown to delay ovarian cancer relapse
By Deena Beasley CHICAGO (Reuters) - A cancer drug sold by GlaxoSmithKline was shown in a clinical trial to extend by several months...
Read More »By Deena Beasley CHICAGO (Reuters) - A cancer drug sold by GlaxoSmithKline was shown in a clinical trial to extend by several months...
Read More »FRANKFURT (Reuters) - Merck KGaA's cancer drug Erbitux was shown to be more effective at prolonging the lives of bowel cancer patien...
Read More »By Maurice Tamman (Reuters) - A federal judge lifted a 33-year-old injunction barring public access to a confidential database of Me...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Some good news for people who enjoy restraints, riding crops and floggers in the bed...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Kids who are short for their age but otherwise healthy probably don't need extensive ...
Read More »ROME (Reuters) - Italy reported its first case of the SARS-like coronavirus on Friday, a 45-year-old man who had been travelling in ...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Taking "good" bacteria known as probiotics may help prevent diarrhea brought on by a...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Offering a dip alongside vegetables encourages kids to eat veggies they might normally pu...
Read More »By David Lawder and Margaret Chadbourn WASHINGTON (Reuters) - Slower growth in U.S. healthcare costs improved the budget outlook for...
Read More »
PARIS (Reuters) - France will ban electronic cigarette smoking in public places by imposing the same curbs enforced since 2007 to co...
Read More »